Combination of GAS5 with gefitinib markedly reduced the levels of phospho-IGF-1R, pEGFR, and the downstream signaling proteins pAKT and pERK, thus inhibiting tumor growth [108]. This evidence concerns the gene IGF1R and neoplasm.